Abstract:Objective. Interleukin 33 (IL-33) is a novel cytokine involved in joint inflammation in animal models. We analyzed the expression of IL-33 in the serum and synovial fluid of patients with rheumatoid arthritis (RA) and investigated its possible pathophysiological importance. Methods. The concentration of IL-33 was measured by ELISA in the serum of 223 patients with RA and 159 controls. Anticyclic citrullinated peptide, rheumatoid factor (RF)-IgA, and RF-IgG were tested by ELISA. Antikeratin antibody and antiperinuclear factor were tested by indirect immunofluorescence assay. Erythrocyte sedimentation rate, C-reactive protein, and immunoglobulins were measured by standard laboratory techniques. The association of IL-33 level with clinical and serologic features of RA was analyzed. We tested the change of IL-33 level following tumor necrosis factor (TNF-alpha) blockade therapy in 40 patients with RA. Results. In contrast to almost no detectable IL-33 in osteoarthritis and healthy serum, IL-33 could be detected in 94 out of the 223 RA cases (42.2%). Serum IL-33 concentration was significantly higher in patients with RA than in control groups. The level of serum IL-33 decreased after anti-TNF treatment. The level of serum IL-33 was correlated with the production of IgM and RA-related autoantibodies including RF and anticitrullinated protein antibodies. However, no correlation was found between IL-33 concentration and acute-phase inflammation reactant or the score of the Disease Activity Index, suggesting a complex or indirect character of the link between IL-33 and the inflammation in RA. Conclusion. The level of IL-33 is abnormally elevated in RA serum. The elevation of serum IL-33 was at least partly attributed to excessive TNF-alpha in RA. IL-33 might be involved in the regulation of autoantibody production in RA. (First Release August I 2010; J Rheumatol 2010;37:2006-13; doi:10.3899/jrheum.100184)

Change of Interleukin-17 Level in Rheumatoid Arthritis Patients

Serum Levels of IL-1, TNF-α, IL-2, IFN-γ and Neopterin in Patients with Rheumatoid Arthritis

[Serum Levels of Several Chemokines in Patients with Rheumatoid Arthritis].

Clinical significance of serum sICAM-1 and sE-selectin in patients with active rheumatoid arthritis

Expression of Interleukin-18, Il-18bp, and Il-18r in Serum, Synovial Fluid, and Synovial Tissue in Patients with Rheumatoid Arthritis

Upregulated Expression of microRNA-16 Correlates with Th17/Treg Cell Imbalance in Patients with Rheumatoid Arthritis.

Expression of RNATES,MCP-1 in serum and synovial fluid in patients with rheumatoid arthritis and its clinical significance

Possible Mechanisms of Peripheral Elevated Cd8+IL-17+ T Cells in Rheumatoid Arthritis

Serotoninergic involvement in the cimetidine-induced prolactin release.

Overwhelming Th17 cells compared to insufficient CD4+ regulatory T cells in rheumatoid arthritis

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

The Change of CD4+CD25+ Regulatory T Cells in Patients with Rheumatoid Arthritis

The detection of interleukin-33 and the correlated research of interleukin-33 and early rheumatoid arthritis

Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis

Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients

Elevated Th22 Cells Correlated with Th17 Cells in Patients with Rheumatoid Arthritis

Autoantibodies Against Interleukin-21 Correlate with Disease Activity in Patients with Rheumatoid Arthritis

Targeting Interleukin-21 in Rheumatoid Arthritis

Changes and Clinical Significance of Peripheral Blood CD8 +CD25 +T Cells in Rheumatoid Arthritis Patients

Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis

Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis.